Disrupted Healthcare – 18 Deals and Investments This Week

VC Deals (7 deals, $120M)

ObsEva, a Swiss developer of drugs that address “serious conditions compromising pregnancy from conception to birth,” has raised around $60 million in Series B funding. HBM Healthcare Investments, New Enterprise Associates, OrbiMed and Rock Springs Capital were joined by return backers , Sofinnova Ventures, Novo Ventures and MS Ventures

PatientPop, a Santa Monica, Calif.-based healthcare practice growth platform, has raised $10 million in Series A funding led by Toba Capital. It previously raised a $3.3 million seed round led by AthenaHealth

HealthCrowd, a San Mateo, Calif.-based provider of healthcare mobile messaging solutions, has raised $2.1 million in new seed funding. Backers include Startup Capital Ventures, Herlitz Capital, Healthy Ventures, Band of Angels, Berkeley Angel Network, and 37 Angels

Vector Watch, a Bucharest-based developer of a low-power operating system for wearables, has raised $5 million in VC funding. GECAD Group led the round, and was joined by Catalyst Romania

BAROnova, a nine-year-old, Goleta, Ca.-based medical tech company that’s developing devices to treat obesity, has raise $36.5 million in Series D funding co-led by Delos Capital and Longitude Capital. Earlier backers Lumira Capital Partners, ONSET Ventures and Sante Ventures also joined the round

Wearable and fitness technology startup Goqii, started last year by Indian entrepreneur Vishal Gondal, has raised US$13.4 million in series A funding led by New Enterprise Associates (NEA)

Location-based app for finding patient-reviewed clinics in the vicinity and booking doctor appointments, Medinfi has raised an angel round of $300,000 from a group of investors

PE Deals (2 deals)

Forefront Dermatology, a Manitowoc, Wis.-based dermatology practice network backed by Varsity Healthcare Partners, has acquired Premier Dermatology, a Crest Hill, Ill.-based dermatology practice with 10 providers in six offices. No financial terms were disclosed

Wellspring Capital Management has acquiredAdvoServ, a Bear, Del.-based behavioral healthcare provider focused on clinical, educational and residential services services for children and adults with severe intellectual and developmental disabilities and dual diagnoses. No financial terms were disclosed. The seller was GI Partners

IPO Deals (2 deals)

TSG Consumer Partners has agreed to sell DenTek Oral Care Inc., a Maryville, Tenn.-based provider of oral care products like dental picks, toPrestige Brands Inc.(NYSE: PBH) for $225 million (on a cash-free, debt-free basis)

Therapure Biopharma Inc., an Ontario-based biologics therapeutics company backed by Catalyst Capital Group, is prepping a C$100 million IPO

Other Deals (7 deals)

Biosense Webster Inc., a subsidiary of Johnson & Johnson (NYSE: JNJ), has acquired Coherex Medical Inc., a Salt Lake City-based developer of catheter-based technologies for the treatment of structural heart defects. No financial terms were disclosed. Coherix had raised over $30 million in VC funding from firms like Oxford Bioscience Partners and Psilos Group

AstraZeneca (LSE: AZN) has agreed to sell the U.S. rights for its Crohn’s disease drug Entocort to Perrigo Company PLC (NYSE: PRGO) for $380 million. The deal is expected to close by year-end

Shire PLC (Nasdaq: SHPG) is preparing a new takeover offer for biotech company Baxalta (NYSE: BXLT), which in August rejected a $30.6 billion all-stock bid

Francisco Partners has agreed to sell Healthand Holding Inc., a Minnesota-based provider of electronic health records and clinical information management solutions to hospitals, to Computer Programs and Systems Inc. (Nasdaq: CPSI) for approximately $250 million

Reprocell (Jasdaq: 4978) has acquired Biopta, a Glasgow-based company that uses functional human tissue to predict drug activity prior to clinical trials. No financial terms were disclosed. Biopta shareholders include Braveheart Investment Group, E-Synergy, LINC Scotland and The Scottish Investment Bank

Merck KGaA is considering the sale of its allergy unit (Allergopharma), which could be valued at around €600 million

Portea Medical, an India based home healthcare company, has acquired speciality pharmaceutical distributor MedybizPharma for an undisclosed amount

Sources: Term Sheet, Financial Times, StrictlyVC, TechinAsia, CrunchBase, TechCrunch, Bloomberg

The Propell Group

#healthtech #asia